World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
23624
World Ranking
13776
National Ranking
6991

Overview

Ronald D. Alvarez is affiliated with Vanderbilt University Medical Center in the United States and has contributed extensively to medical research, particularly in the intersections of oncology, reproductive medicine, and obstetrics and gynecology. Their work spans a total of 58 publications primarily in the field of medicine.

Their research covers several specialized subfields including:

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Gender Studies

Alvarez's main research topics include:

  • Ovarian cancer diagnosis and treatment
  • Diversity and Career in Medicine
  • Endometrial and Cervical Cancer Treatments
  • Intraperitoneal and Appendiceal Malignancies
  • PARP inhibition in cancer therapy
  • Social Media in Health Education
  • Health and Medical Research Impacts

The scientist has authored papers published in multiple high-impact venues. Frequently published journals include:

  • Gynecologic Oncology
  • American Journal of Obstetrics and Gynecology
  • Journal of the National Comprehensive Cancer Network
  • Gynecologic Oncology Reports
  • UNC Libraries

Notable recent publications by Alvarez include:

  • Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology, 2021, Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022, 2022, Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024, 2024, Journal of the National Comprehensive Cancer Network
  • Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer, 2020, Gynecologic Oncology
  • Early resynchronization of non-pregnant beef cows based in corpus luteum blood flow evaluation 21 days after Timed-AI, 2020, Theriogenology

Alvarez has collaborated frequently with several researchers, indicating a network of professional co-authorships. Frequent co-authors include:

  • Marta A. Crispens
  • Charles A. Leath
  • Barbara A. Goff
  • Deborah K. Armstrong
  • Premal H. Thaker

Best Publications

  • Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

    Tyler J Curiel;Shuang Wei;Haidong Dong;Xavier Alvarez

  • Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study

    Franco M. Muggia;Patricia S. Braly;Mark F. Brady;Gregory Sutton

  • Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

    Larry C. Kilgore;Edward E. Partridge;Ronald D. Alvarez;J.Maxwell Austin

  • Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group

    J. Tate Thigpen;Mark F. Brady;Ronald D. Alvarez;Mark D. Adelson

  • Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial

    Maurie Markman;P.Y. Liu;Sharon Wilczynski;Bradley Monk

  • Ovarian cancer, version 2.2020

    Deborah K. Armstrong;Ronald D. Alvarez;Jamie N. Bakkum-Gamez;Lisa Barroilhet

  • Stem cell pathways contribute to clinical chemoresistance in ovarian cancer

    Adam D. Steg;Kerri S. Bevis;Ashwini A. Katre;Angela Ziebarth

  • Targeting Adenovirus to the Serotype 3 Receptor Increases Gene Transfer Efficiency to Ovarian Cancer Cells

    Anna Kanerva;Galina V. Mikheeva;Victor Krasnykh;Candace J. Coolidge

  • Ovarian cancer, version 1.2016: Clinical practice guidelines in oncology

    Robert J. Morgan;Deborah K. Armstrong;Ronald D. Alvarez;Jamie N. Bakkum-Gamez

  • Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix

    Ronald D. Alvarez;Seng-Jaw Soong;Walter K. Kinney;Gary C. Reid

  • NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.

    Deborah K Armstrong;Ronald D Alvarez;Jamie N Bakkum-Gamez;Lisa Barroilhet

  • Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study.

    Ronald D. Alvarez;Edward E. Partridge;M.B. Khazaeli;Gene Plott

  • Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.

    Anna Kanerva;Minghui Wang;Gerd J. Bauerschmitz;John T. Lam

  • Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.

    Gerd J. Bauerschmitz;John T. Lam;Anna Kanerva;Kaori Suzuki

  • Differences in Immune Responses Induced by Oral and Rectal Immunizations with Salmonella typhi Ty21a: Evidence for Compartmentalization within the Common Mucosal Immune System in Humans

    A. Kantele;A. Kantele;M. Häkkinen;M. Häkkinen;Z. Moldoveanu;A. Lu

  • Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus.

    Anna Kanerva;Kurt R Zinn;Tandra R Chaudhuri;John T Lam

  • A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.

    Ronald D. Alvarez;Mack N. Barnes;Jesus Gomez-Navarro;Minghui Wang

  • Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.

    Warner K Huh;Matthew Powell;Charles A Leath;J.Michael Straughn

  • Conservative Management of Stage I Endometrial Carcinoma after Surgical Staging

    J.Michael Straughn;Warner K. Huh;F.Joseph Kelly;Charles A. Leath

  • Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.

    Rebecca C. Arend;Angelina I. Londoño-Joshi;Rajeev S. Samant;Yonghe Li

Frequent Co-Authors

David T. Curiel
David T. Curiel Washington University in St. Louis
Gene P. Siegal
Gene P. Siegal University of Alabama at Birmingham
Akseli Hemminki
Akseli Hemminki University of Helsinki
Charles N. Landen
Charles N. Landen University of Virginia
William E. Grizzle
William E. Grizzle University of Alabama at Birmingham
Chien-Fu Hung
Chien-Fu Hung Johns Hopkins University
Albert F. LoBuglio
Albert F. LoBuglio University of Alabama at Birmingham
David E. Cohn
David E. Cohn The Ohio State University
Igor Dmitriev
Igor Dmitriev Washington University in St. Louis
Victor Krasnykh
Victor Krasnykh The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to multiple online degree options and nursing career pathways. For students seeking flexible, affordable alternatives, there are several accredited programs tailored to your needs and budget.

Many aspiring nurses start with cheap online nursing programs that offer solid foundational training at a lower cost. If you are a registered nurse looking to advance your career, consider cheap rn to bsn programs for bachelor’s-level credentials without financial strain.

Those aiming for the highest clinical roles can take advantage of cheapest dnp programs, which prepare nurses for leadership and specialized practice. Meanwhile, if your background isn’t in nursing but you want to pivot careers, direct entry msn programs for non-nurses online provide a streamlined path for non-nursing graduates.

With a variety of affordable online options available, students and professionals at any stage can find a program suited to their goals and budget.

Best Scientists Citing Ronald D. Alvarez

Trending Scientists

Recently Published Articles